Grant: Master's Award: Canada Graduate Scholarships
University of Ottawa
$17,500.00
Proposing Legislative Reforms for Equitable Neurotechnology Access in Cases of MAiD MD-SUMC in Canada
FY 2023-24
Summary
Medical Assistance in Dying (MAiD) is a sanctioned medical procedure, allowing individuals with severe illnesses to choose a dignified end to their lives. Up until recently, Canada limited its access to unbearable physical ailments. However, as of March 2024, MAiD eligibility will extend to those dealing with psychiatric conditions, such as depression and personality disorders. This amendment introduces ethical dilemmas, as clinicians disagree on what is ‘irremediable’ enough to warrant MAiD approval in these cases. I will argue that we have a duty to offer individuals seeking MAiD innovative neurotechnology, such as brain stimulation treatments, before confirming irremediability. The proposed study will address two obstacles currently hindering the fulfillment of this duty: stringent approval regulations for non-traditional neurotechnology and insufficient funding for accessing these treatments. Specifically, ethical gaps within Canadian legislative frameworks will be identified through a scoping review and stakeholder perspectives will be considered by interviewing individuals in medical, legal, ethical, and corporate contexts. Additionally, the study will examine the use of medical technologies in contexts similar to MAiD outside of Canada to gain insights for enhancing our mental healthcare system. I anticipate that integrating new neurotechnology legislation into existing MAiD criteria can align with Canada's present legal framework and objectives. Ultimately, this research will contribute to the ongoing discourse on assisted dying for mental disorders. Beyond the scope of MAiD, this investigation also advocates for access to non-traditional treatments for various clinical populations, ensuring an ethically sound approach to critical-care decisions in Canada
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
506305
Name
Urian Diana M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Proposing Legislative Reforms for Equitable Neurotechnology Access in Cases of MAiD MD-SUMC in Canada
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Healthcare Equity; Legal Framework; Medical Assistance In Dying; Medical Ethics; Mental Healthcare Funding; Neurolaw; Neurotechnology; Non-Traditional Interventions; Policy Development; Public Policy
Abstract
Medical Assistance in Dying (MAiD) is a sanctioned medical procedure, allowing individuals with severe illnesses to choose a dignified end to their lives. Up until recently, Canada limited its access to unbearable physical ailments. However, as of March 2024, MAiD eligibility will extend to those dealing with psychiatric conditions, such as depression and personality disorders. This amendment introduces ethical dilemmas, as clinicians disagree on what is ‘irremediable’ enough to warrant MAiD approval in these cases. I will argue that we have a duty to offer individuals seeking MAiD innovative neurotechnology, such as brain stimulation treatments, before confirming irremediability. The proposed study will address two obstacles currently hindering the fulfillment of this duty: stringent approval regulations for non-traditional neurotechnology and insufficient funding for accessing these treatments. Specifically, ethical gaps within Canadian legislative frameworks will be identified through a scoping review and stakeholder perspectives will be considered by interviewing individuals in medical, legal, ethical, and corporate contexts. Additionally, the study will examine the use of medical technologies in contexts similar to MAiD outside of Canada to gain insights for enhancing our mental healthcare system. I anticipate that integrating new neurotechnology legislation into existing MAiD criteria can align with Canada's present legal framework and objectives. Ultimately, this research will contribute to the ongoing discourse on assisted dying for mental disorders. Beyond the scope of MAiD, this investigation also advocates for access to non-traditional treatments for various clinical populations, ensuring an ethically sound approach to critical-care decisions in Canada
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Urian, Diana M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~